China Dialysis Market Analysis Report 2022 to 2030

China Dialysis Market Analysis

$ 3999

China's Dialysis Market is projected to grow from $9.342 Bn in 2022 to $17.291 Bn by 2030, registering a CAGR of 8.0% during the forecast period of 2022-30. The incidence of chronic kidney disease is increasing in China due to factors such as diabetes, hypertension, and obesity. This is expected to drive the demand for dialysis treatment. Some key players in the China dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, B. Braun Melsungen AG, and Weigao Group.

ID: IN10CNPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Shivam Zalke

Buy Now

China Dialysis Market Executive Summary

China's Dialysis Market is projected to grow from $9.342 Bn in 2022 to $17.291 Bn by 2030, registering a CAGR of 8.0% during the forecast period of 2022-30.

The China dialysis market is a rapidly growing market, driven by an ageing population, an increase in chronic kidney disease, and a lack of kidney donors.

In China, the dialysis market is primarily dominated by in-centre hemodialysis, which accounts for the majority of dialysis treatments. However, home dialysis is also becoming more popular as it provides greater convenience and flexibility for patients. The Chinese government has also been investing in the development of home dialysis in recent years.

The Chinese government plays an important role in the dialysis market through its reimbursement policies and regulations for dialysis clinics. The government regulates the prices of dialysis products and services, and also provides subsidies for dialysis treatment for low-income patients. Additionally, the government is also investing in the expansion of dialysis facilities in rural areas to increase access to dialysis treatment for patients in these regions.

There are many domestic and international players present in the Chinese dialysis market, such as Fresenius Medical Care, Baxter International, and Nipro Medical Corporation.

Overall, the market is expected to grow significantly in the forecasted period, driven by the increasing prevalence of chronic kidney disease and an aging population.

china dialysis market analysis

Market Dynamics

Market Drivers

The key drivers of the China dialysis market include:

Aging Population: The aging population in China is expected to drive the demand for dialysis treatment, as the risk of chronic kidney disease increases with age
Increase in Chronic Kidney Disease: The incidence of chronic kidney disease is increasing in China due to factors such as diabetes, hypertension, and obesity. This is expected to drive the demand for dialysis treatment
Lack of Kidney Donors: The shortage of kidney donors in China is driving the demand for dialysis treatment as a long-term solution for patients with end-stage renal disease
Government Support: The Chinese government is investing in the expansion of dialysis facilities and providing subsidies for dialysis treatment for low-income patients. This is expected to increase access to dialysis treatment and drive market growth
Technological Advancements: Advancements in dialysis technology such as home dialysis equipment and more efficient dialysis machines, are expected to drive the market growth
Rising healthcare expenditure: With China's growing economy, the expenditure on healthcare is also increasing, which is expected to drive market growth

Competitive Landscape

Key Players

Some key players in the China dialysis market include

Fresenius Medical Care
Baxter International
Nipro Medical Corporation
B. Braun Melsungen AG
Weigao Group

These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment. Other notable companies in the market include DaVita, Shijiazhuang Kidney Disease Hospital, and Huaren Pharmaceutical Group.

Healthcare Policies and Regulatory Landscape

The Chinese government has implemented several policies and regulations to support the development of the dialysis market in the country. Some of these include:

The "Healthy China 2020" plan, aims to improve the overall health of the population and increase access to healthcare services, including dialysis
The "National Basic Public Health Service Standards" includes guidelines for the provision of dialysis services, including the number of dialysis machines and staff required per facility
The "Medical Device Supervision and Management Regulations" include regulations for the registration, inspection, and quality control of dialysis equipment and supplies
The "Catalogue of Medical Devices for Insurance Reimbursement" lists the dialysis equipment and supplies that are eligible for reimbursement under the country's medical insurance system
The "New Rural Cooperative Medical Care System" aims to increase access to healthcare services in rural areas, including dialysis
The "Healthy China 2030" plan aims to improve the overall health of the population and increase access to healthcare services, including dialysis

These policies and regulations have helped to create a favorable environment for the development of the dialysis market in China, and are expected to continue to support its growth in the future.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.